Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,555 active trials61 approved drugs296 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,552 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,964)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05247619 | A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer | unknown | Phase 2 | 49 | Zhejiang Cancer HospitalOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT05455736 | STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational Study(STARR) | unknown | — | 90 | Azienda Ospedaliero-Universitaria Careggi |
| 1 |
| Jul 13, 2022 |
| clinicaltrials |
| NCT05444374 | A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer | unknown | Phase 2 | 48 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT03827837 | Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors | unknown | Phase 2 | 265 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05122221 | CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers | unknown | Phase 1 | 12 | Corregene Biotechnology Co., LtdINDUSTRY | 1 | Jun 28, 2022 | clinicaltrials |
| NCT05427864 | Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging | unknown | N/A | 47 | Gulhane Training and Research HospitalOTHER_GOV | 1 | Jun 28, 2022 | clinicaltrials |
| NCT05430737 | A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer | unknown | N/A | 60 | West China HospitalOTHER | 1 | Jun 24, 2022 | clinicaltrials |
| NCT04116775 | Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. | unknown | Phase 2 | 32 | Julie Graff, MDFED | 1 | Jun 23, 2022 | clinicaltrials |
| NCT03284151 | Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma | unknown | — | 26 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT04864431 | Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian Cancer(VitD) | unknown | N/A | 54 | Indonesia UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05252806 | Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer(QmpMRI) | unknown | — | 30 | Radboud University Medical CenterOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05078359 | Optimizing Positive Predicting Value of Prostate MRI(PROMOD) | unknown | — | 5,000 | Ospedali Riuniti di FoggiaOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05422183 | Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer | unknown | Phase 2 | 20 | Zhongda HospitalOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT03588819 | Stereotactic MRI-Guided Radiation for Localized Prostate Cancer(2SMART) | unknown | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Jun 14, 2022 | clinicaltrials |
| NCT05410015 | Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer | unknown | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT05410028 | New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence | unknown | — | 1,000 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT04278261 | Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer | unknown | N/A | 216 | Shanghai East HospitalOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT04982146 | Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei | unknown | Phase 1 | 10 | Maimónides Biomedical Research Institute of CórdobaOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05392634 | Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery(MACS) | unknown | Phase 3 | 98 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT05387460 | Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer | unknown | — | 2,000 | Tongji HospitalOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05385068 | A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi(t) | unknown | Phase 2 | 35 | Peking Union Medical College HospitalOTHER | 0 | May 23, 2022 | clinicaltrials |
| NCT05382182 | Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021 | unknown | — | 100 | Sohag UniversityOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT04718987 | Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate Brachytherapy(PRIAPUS) | unknown | N/A | 10 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT05187949 | Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer(PROSHADE) | unknown | — | 1,781 | Universidad Miguel Hernandez de ElcheOTHER | 0 | May 17, 2022 | clinicaltrials |
| NCT05375526 | Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer | unknown | N/A | 10 | Maastricht University Medical CenterOTHER | 1 | May 16, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT03780075 | Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 | 50 | Peking Union Medical College HospitalOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05371301 | Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05372302 | Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)(CICERONE) | unknown | — | 100 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT04718948 | Multimodal Spectroscopy to Detect Urothelial Cancer in Urine | unknown | — | 500 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04770974 | Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic | unknown | — | 200 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04854343 | SLPI for Prostate Cancer | unknown | — | 280 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03235687 | Decision Impact Trial of the ExoDx Prostate (IntelliScore) | unknown | N/A | 1,000 | Exosome Diagnostics, Inc.INDUSTRY | 1 | May 6, 2022 | clinicaltrials |
| NCT04251546 | Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV | unknown | — | 80 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT04856306 | Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L(Magical) | unknown | — | 300 | Medstar Health Research InstituteOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT04866394 | Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS(SPARTACUS) | unknown | N/A | 40 | Sunnybrook Health Sciences CentreOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05362669 | SMS Messaging for Invitation in the Cervical Cancer Screening Programme(CERCA-SMS) | unknown | N/A | 450 | Institut Català d'OncologiaOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05359913 | Podcasting Cervical Cancer Prevention for AAW | unknown | N/A | 40 | University of HoustonOTHER | 0 | May 4, 2022 | clinicaltrials |
| NCT05154474 | Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy(SPACE2) | unknown | — | 150 | WepromOTHER | 1 | May 3, 2022 | clinicaltrials |
| NCT05344937 | Validation Study of Uromonitor in High Risk Microhematuria Patients | unknown | — | 343 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT05355727 | PROSAIC-DS Study (PROState AI in Cancer - Decision Support)(PROSAIC-DS) | unknown | N/A | 1,040 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT04300673 | Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients(DETECT) | unknown | Phase 1 / Phase 2 | 20 | Radboud University Medical CenterOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT05297162 | PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial(PROSPET-BX) | unknown | N/A | 128 | Istituto Clinico HumanitasOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT04033432 | sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | unknown | Phase 2 | 14 | Northwestern UniversityOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT02033616 | Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas | unknown | Phase 2 | 99 | Aivita Biomedical, Inc.INDUSTRY | 1 | Apr 25, 2022 | clinicaltrials |
| NCT02849535 | Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer(PRISM care) | unknown | N/A | 190 | Hospices Civils de LyonOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT04229615 | A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy | unknown | Phase 3 | 690 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 25, 2022 | clinicaltrials |
| NCT03961737 | Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers(EXPLANT) | unknown | N/A | 92 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 22, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Jul 15, 2022source: clinicaltrials